CompaniesKamau Therapeutics
Kamau Therapeutics logo

Kamau Therapeutics

active
South SF, CA, United States
Founded 2023
Website
About

Gene Correction Technology

Areas of Focus

Categories

Biotech
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

15

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT04819841
Hover over trial bars to see details

Recent Trials

NCT04819841Lead Sponsor
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
PHASE1/PHASE2Recruiting
15 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2028
Funding History (1)
D
Jun 3, 2025
Filing
Locations (1)
Headquarters
South SF, CA, United States
Map

Loading map...